Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Lancet (London, England)
|
June 23, 2020
Solidarity in the wake of COVID-19: reimagining the International Health Regulations
Allyn L Taylor, Roojin Habibi, Gian Luca Burci, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 15, 2024
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial
Ying Liu, Jacquelyn Bainbridge, Stefan Sillau, et al.
Lancet (London, England)
|
February 17, 2020
Do not violate the International Health Regulations during the COVID-19 outbreak
Roojin Habibi, Gian Luca Burci, Thana C de Campos, et al.
Bulletin of the World Health Organization
|
March 9, 2022
Travel restrictions and variants of concern: global health laws need to reflect evidence
Benjamin Mason Meier, Judith Bueno de Mesquita, Gian Luca Burci, et al.
Bulletin of the World Health Organization
|
February 12, 2013
Universal health coverage anchored in the right to health
Gorik Ooms, Claire Brolan, Natalie Eggermont, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis
Adrielly Martins, Anish Reddy, Richard Dean, et al.
Science (New York, N.Y.)
|
November 19, 2005
Epidemiology. DNA identifications after the 9/11 World Trade Center attack
Leslie G Biesecker, Joan E Bailey-Wilson, Jack Ballantyne, et al.
Hepatology Communications
|
January 29, 2024
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis
Maryam Yazdanfar, Joseph Zepeda, Richard Dean, et al.
Hepatology (Baltimore, Md.)
|
June 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Lancet (London, England)
|
June 23, 2020
Solidarity in the wake of COVID-19: reimagining the International Health Regulations
Allyn L Taylor, Roojin Habibi, Gian Luca Burci, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 15, 2024
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial
Ying Liu, Jacquelyn Bainbridge, Stefan Sillau, et al.
Lancet (London, England)
|
February 17, 2020
Do not violate the International Health Regulations during the COVID-19 outbreak
Roojin Habibi, Gian Luca Burci, Thana C de Campos, et al.
Bulletin of the World Health Organization
|
March 9, 2022
Travel restrictions and variants of concern: global health laws need to reflect evidence
Benjamin Mason Meier, Judith Bueno de Mesquita, Gian Luca Burci, et al.
Bulletin of the World Health Organization
|
February 12, 2013
Universal health coverage anchored in the right to health
Gorik Ooms, Claire Brolan, Natalie Eggermont, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis
Adrielly Martins, Anish Reddy, Richard Dean, et al.
Science (New York, N.Y.)
|
November 19, 2005
Epidemiology. DNA identifications after the 9/11 World Trade Center attack
Leslie G Biesecker, Joan E Bailey-Wilson, Jack Ballantyne, et al.
Hepatology Communications
|
January 29, 2024
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis
Maryam Yazdanfar, Joseph Zepeda, Richard Dean, et al.
Hepatology (Baltimore, Md.)
|
June 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein, et al.
Page
of 10